- Home
- XYF vs HUMA Comparison
XYF vs HUMA Comparison
Compare XYF & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XYF | HUMA |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.1M | 165.7M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | XYF | HUMA |
|---|---|---|
| Price | $4.82 | $0.43 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.63 |
| AVG Volume (30 Days) | 47.9K | ★ 5.7M |
| Earning Date | 11-19-2026 | 11-11-2026 |
| Dividend Yield | ★ 11.53% | N/A |
| EPS Growth | N/A | ★ 79.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,038,000.00 |
| Revenue This Year | N/A | $72.32 |
| Revenue Next Year | N/A | $518.79 |
| P/E Ratio | $0.90 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.30 | $0.34 |
| 52 Week High | $13.16 | $1.78 |
Technical Indicators
Market Signals| Indicator | XYF | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 41.96 |
| Support Level | $4.62 | $0.34 |
| Resistance Level | $5.12 | $0.46 |
| Average True Range (ATR) | 0.20 | 0.04 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 14.09 | 55.07 |
Price Performance
Historical ComparisonAbout XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, guarantee services provided and financing income.
About HUMA Humacyte Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.